Targeting Rab27A with covalent inhibitors and Exocytosis TArgeting Chimeras (ExoTACs) for lung cancer treatment
Targeting Rab27A with covalent inhibitors and Exocytosis TArgeting Chimeras (ExoTACs) for lung cancer treatment
批准号:
EP/X02749X/1
负责人:
Edward Tate
金额:
$26.0万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Small monomeric guanosine triphosphatases (GTPases) are a group of hydrolase enzymes that bind to and hydrolyse a guanosine triphosphate (GTP) to form guanosine diphosphate (GDP). GTP-bound small GTPases can recruit specific effectors through protein-protein interactions (PPIs) to trigger signalling cascades in cells. Rab27A is a small GTPase protein playing a key role in secretion of exosomes, membrane-bound vesicles responsible for intercellular communication and cell migration. GTP-bound Rab27A mediates the release of exosomes by binding to its effectors such as Slp2a. Several studies have shown that loss of Rab27A expression impairs cancer cell invasion and metastasis due to reduction of pro-invasive exosomes. Therefore, targeting Rab27A is a promising strategy to overcome metastasis and drug resistance in lung cancer. However, Rab27A is a very challenging target due to its conformational flexibility and the lack of canonical binding pockets beyond the widely conserved GTP binding site. The host lab (Tate) used a covalent ligand approach to target two non-conserved cysteines in proximity to the effector binding site on Rab27 isoforms and identified the first bona fide Rab27A ligand series, with optimized hits exhibiting high selectivity for Cys123, strong interference with the Rab27A-Slp2 effector PPI, and moderate proteome-level selectivity (unpublished results). In this project, I will (1) optimize these starting points to design the first proteome-wide selective Rab27A inhibitor to interfere with its binding to effectors, subsequently (2) characterizing its impact on exosome secretion, invasion and growth of lung cancer cells. In the second part of the project, I will (3) develop a new class of bifunctional molecules termed Exocytosis TArgeting Chimeras (ExoTACs), linking a selective Rab27A ligand with a ligand to a target protein, enabling for the first time compound-induced exocytosis of a target protein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A proteomics platform to enable next generation multidisciplinary bioscience
-
批准号:BB/W019574/1
-
项目类别:Research Grant
-
资助金额:$55.29万
-
财政年份:2022
-
负责人:Edward Tate
-
依托单位:
Hedgehog acyltransferase : structure and function in health and disease
-
批准号:BB/T01508X/1
-
项目类别:Research Grant
-
资助金额:$105.41万
-
财政年份:2020
-
负责人:Edward Tate
-
依托单位:
A surface plasmon resonance facility for label-free analysis of biomolecular interactions
-
批准号:BB/S019529/1
-
项目类别:Research Grant
-
资助金额:$23.28万
-
财政年份:2019
-
负责人:Edward Tate
-
依托单位:
N-Myristoyl Transferase as a drug target for anti-malarial therapy
-
批准号:G0900278/1
-
项目类别:Research Grant
-
资助金额:$179.17万
-
财政年份:2010
-
负责人:Edward Tate
-
依托单位:
Novel Chemical Probes of Surface-Layer Formation in Pathogenic Bacteria
-
批准号:G0701834/1
-
项目类别:Research Grant
-
资助金额:$12.01万
-
财政年份:2008
-
负责人:Edward Tate
-
依托单位:
Mapping the acylated proteome: a chemical genetic approach
-
批准号:BB/D02014X/1
-
项目类别:Fellowship
-
资助金额:$92.3万
-
财政年份:2006
-
负责人:Edward Tate
-
依托单位:
国内基金
海外基金
登录
查看更多内容
突触结合样蛋白5通过RAB27a调控甲状腺
乳头状癌转移的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:余诗桐
-
依托单位:
FOS转录调控Rab27a促进肌腱干细胞分泌外泌体修复肌腱损伤机制的研究
-
批准号:JCZRLH202500509
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
Rab27A通过调节miR-124-3p/STAT3轴在浆液性卵巢癌发生中的作用机制研究
-
批准号:2023JJ40822
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺莎莎
-
依托单位:
HIF-1a/Rab27a信号轴调控低氧来源NSC-EXs生成在血管性痴呆治疗中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:潘群文
-
依托单位:
尼古丁通过Samd4b-Klf4/Rab27a通路介导血管平滑肌细胞表型转化促进腹主动脉瘤发生发展的作用机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宋豪语
-
依托单位:
SYTL5通过Rab27a介导外泌体分泌调控甲状腺乳头状癌侵袭转移的机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:余诗桐
-
依托单位:
血管内皮细胞外泌体的Rab27a/lncRNA OIP5-AS1通路对脑神经血管单元的调控作用及其在缺血性脑卒中的意义
-
批准号:82170407
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:马晓瑭
-
依托单位:
高糖条件下Rab27a的O-GlcNAc化修饰参与介导子宫内膜癌细胞外泌体释放及相关机制研究
-
批准号:82002735
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:周福兴
-
依托单位:
磷酸胆碱通过RAB27A激酶上调外泌体释放hsa_circ_0054903干预NOTCH信号通路促进子宫内膜癌间质上皮转化的机制研究
-
批准号:82072859
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:石琨
-
依托单位:
Rab27A调控Stat3信号通路促进非小细胞肺癌转移的机制研究
-
批准号:81802885
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:曾园园
-
依托单位: